Literature DB >> 7391164

High-performance liquid chromatographic analysis of verapamil. II. Simultaneous quantitation of verapamil and its active metabolite, norverapamil.

S R Harapat, R E Kates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7391164

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  19 in total

1.  Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.

Authors:  D L Murdoch; G D Thomson; G G Thompson; G D Murray; M J Brodie; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

2.  Dexverapamil as resistance modifier in acute myeloid leukaemia.

Authors:  R Pirker; S Zöchbauer; H Kupper; A Lassmann; A Gsur; M Frass; G Krajnik; P Knöbl; K Lechner
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 3.  Clinical pharmacokinetics of calcium antagonists. An update.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

4.  Once a day verapamil in essential hypertension.

Authors:  F B Müller; H R Ha; H Hotz; O Schmidlin; F Follath; F R Bühler
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

5.  Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing. Studies with deuterated verapamil.

Authors:  M Eichelbaum; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.

Authors:  R Padrini; E Barbieri; D Piovan; M Toffoli; A Motta; G P Trevi; M Ferrari
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors.

Authors:  F Formelli; L Cleris; R Carsana
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Verapamil in the prophylaxis of bronchial asthma. Is the bronchoprotective effect related to the plasma level?

Authors:  E Imhof; S Elsasser; B Rosmus; H R Ha; F Follath; A P Perruchoud
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

10.  Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients.

Authors:  N T Fuenmayor; B M Faggin; L X Cubeddu
Journal:  Drugs       Date:  1992       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.